Filing search / Inhibrx Biosciences, Inc. / "Hire"

8-K

EX-99.1

INBX Inhibrx Biosciences, Inc.

24 May 24

Inhibrx Inc. Stockholders Approve Sale of INBRX-101 to Sanofi

4:08pm

professionals and to identify, hire and retain additional qualified professionals; and developments relating to the Company’s competitors and the Company’s

DEFA14A

INBX Inhibrx Biosciences, Inc.

20 May 24

Additional proxy soliciting materials

9:48pm

weather events; the ability to retain the continued service of the Company’s key professionals and to identify, hire and retain additional qualified

8-K

INBX Inhibrx Biosciences, Inc.

17 May 24

Other Events

5:29pm

of the Company’s key professionals and to identify, hire and retain additional qualified professionals; and developments relating to the Company’s competitors

DEFA14A

INBX Inhibrx Biosciences, Inc.

17 May 24

Additional proxy soliciting materials

4:25pm

weather events; the ability to retain the continued service of the Company’s key professionals and to identify, hire and retain additional qualified

8-K

EX-99.1

INBX Inhibrx Biosciences, Inc.

9 May 24

Inhibrx Reports First Quarter 2024 Financial Results

4:08pm

to retain the continued service of the Company’s key professionals and to identify, hire and retain additional qualified professionals; and developments

8-K

EX-99.1

8h47uy56ogm7selu36t

8 May 24

Other Events

4:42pm

DEFM14A

3t4nhy q8up6t9cz4

26 Apr 24

Proxy related to merger

4:06pm

DEFA14A

xjucd82e

12 Mar 24

Additional proxy soliciting materials

4:05pm

8-K

cgjrhbhd5ba04

12 Mar 24

Other Events

4:02pm

8-K

EX-99.1

xvq4rv7o

28 Feb 24

Inhibrx Reports Fourth Quarter and Fiscal Year 2023 Financial Results

9:12am

DEFA14A

0asr2

6 Feb 24

Additional proxy soliciting materials

4:30pm

DEFA14A

x1qi9 6dd4q

23 Jan 24

Additional proxy soliciting materials

5:25pm

DEFA14A

w95v ch7z

23 Jan 24

Additional proxy soliciting materials

6:38am

8-K

EX-99.1

pwtqfoixa 5hxrp

23 Jan 24

Inhibrx Announces Sale of INBRX-101 to Sanofi for an aggregate value of up to $2.2B

6:35am

8-K

ukuqmpjhli

23 Jan 24

Inhibrx Announces Sale of INBRX-101 to Sanofi for an aggregate value of up to $2.2B

6:35am

8-K

EX-2.1

60jcp6phrm1hpvxfckm

23 Jan 24

Inhibrx Announces Sale of INBRX-101 to Sanofi for an aggregate value of up to $2.2B

6:35am

8-K

EX-2.2

6i7of51 ncc

23 Jan 24

Inhibrx Announces Sale of INBRX-101 to Sanofi for an aggregate value of up to $2.2B

6:35am